References
- Pudiak CM, Bozarth MA. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 1993;53:1517–24.
- Robinson TE. Stimulant drugs and stress: factors influencing individual differences in the susceptibility to sensitization. In: Kalivas PW, Barnes C, eds. Sensitization of the nervous system, NJ: Telford Press, 1988:145–73.
- Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res 1986;396:157–98.
- Stewart J. Conditioned stimulus control of the expression of sensitization of the behavioral activating effects of opiate and stimulant drugs. In: Gormezano I, Wasserman EA, eds. Learning and memory: behavioral and biological substrates. NJ: Lawerence Erlbaum Publishers; 1992:129–51.
- Stewart J. Neurobiology of conditioning to drugs of abuse. Annals of the New York Acad Sci 1992;654:335–45.
- Post RM, Lockfeld A, Squillace KM, Contel NR. Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 1981;28:755–60.
- Böhme GA, Bon C, Stutzmann, J-M, Possible involvement of nitric oxide in long-term potentiation. Euro J Pharmacol 1991;199:379–81.
- O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci 1991;88:11285–9.
- Williams JH, Errington ML, Li Y-G The search for retrograde messengers in long-term potentiation. Sem in the Neurosci 1993;5:149–58.
- Abekawa T, Ohmori T, Koyama T. Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine. Brain Res 1994;666:147–50.
- Kim H-S, Park W-K. Nitric oxide mediation of cocaine-induced dopaminergic behavior: ambulation-accelerating activity, reverse tolerance and conditioned place preferences in mice. J Pharmacol Exp Ther 1995;275:551–7.
- Ohno M, Watanabe S. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice. Euro J Pharmacol 1995;275:39–44.
- Babey AM, Kolesnikov Y, Cheng J, Nitric oxide and opioid tolerance. Neuropharmacology 1994;33:1463–70.
- London ED, Kimes AS, Vaupel DB. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome. NIDA Res Monogr 1995;147:170–81.
- Pasternak GW. When it comes to opiates, just say NO. J Clin Invest 2007;117:3185–7.
- Vaupel DB, Kimes AS, London ED. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology 1995;13: 315–322.
- Byrnes JJ, Pantke MM, Onton JA, Hammer Jr RP. Inhibition of nitric oxide synthase in the ventral tegmental area attenuates cocaine sensitization in rats. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:261–73.
- Itzhak Y. Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase. Neuropharmacology 1996;35:1065–73.
- Pudiak CM, Bozarth MA. Nitric oxide synthesis inhibition attenuates haloperidol-induced supersensitivity. J Psychiatry Neurosci 1997;22:61–4.
- Celik T, Zaglí U, Kayír H, Uzbay IT. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend. 1999;56:109–13.
- Calignano A, Persico P, Mancuso F, Sorrentino L. Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur J Pharmacol 1993;231:415–9.
- Chapman PF, Atkins CM, Allen MT, Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport 1992;3:567–70.
- Kolesnikov YA, Pick CG, Pasternak GW. NG-Nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 1992;221:399–400.
- Itzhak Y. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharm Exp Therap 1997;282:521–7.
- Itzhak Y, Martin JL. Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on methylphenidate-induced hyperlocomotion in mice. Behav Pharmacol 2002;13:81–86.
- Herman BH, Vocci F, Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 1995;13:269–293.
- Kimes AS, Vaupel DB, London ED. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology (Berl). 1993;112:521–4.
- Banting JD, Friberg P, Adams MA. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelium vasoconstriction. J Hypertens 1996;14:975–81.
- Kostic MM, Petronijevic MR, Jakovljevic VLJ. Role of nitric oxide (NO) in the regulation of coronary circulation. Physiol Res 1996;45:273–8.
- Sandi C, Venero C, Guaza C. Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur J Pharmacol 1995;277:89–97.
- Ayers NA, Kapás, Krueger JM. The inhibitory effects of Nω-Nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro. Neurochemical Research. 1997;22:81–6.
- Dwyer MA, Bredt DS, Snyder SH. Nitric oxide synthase: irreversible inhibition by L-NC-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun 1991;176:1136-41.
- Bozarth MA, Pudiak CM, Morris M. Nitric oxide synthesis inhibition does not affect brain stimulation reward. Pharmacol Biochem Behav 1994;48:487–490.
- Pudiak CM, Bozarth MA. The effect of nitric oxide synthesis inhibition on intravenous cocaine self-administration. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:189–196.